Article
Minimal Residual Disease Using Liquid Biopsies in Hematological Malignancies
2022-01-25
Abstract excerpt
The study of cell-free DNA (cfDNA) and other peripheral blood components (known as “liquid biopsies”) is promising and has been investigated especially in solid tumors. Nevertheless, it is increasingly showing greater utility in the diagnosis, prognosis, and response to treatment of hematological malignancies; in the future, it could prevent invasive techniques, such as bone marrow (BM) biopsy. Most of...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- eaf28885-e666-5993-b0ef-28b0784a33e8
- DOI
- 10.20944/preprints202201.0366.v1
